BCR-ABL1 quantitation and mutation analysis
A long PCR method was used to sequence the myristate binding domain using the following primers: Long2F 5′ ACT ATG AGC GTG CAG AGT GGA 3′ and Long2R 5′ GAG GGA GCA ATG GAG ACA CG 3′. A second-stage PCR used the forward primers: Seq1-220F 5′ CGC AAC AAG CCC ACT GTC T 3′ and Seq2-316F 5′ GAG TTC ATG ACC TAC GGG AAC CT 3′ and the reverse primer: Seq1-505R 5′ TTC GTC TGA GAT ACT GGA TTC CTG 3′.
Western blotting for Bcr-Abl
Following lysis in Igepal™ detergent (SigmaAldrich, St Louis, MO, USA), 40 μg protein was resolved on a BIO-RAD 4-15% Criterion TM TGX TM Precast Gel and transferred to PVDF membrane using Midi Transfer Packs (BIO-RAD, Hercules, CA, USA) at 2.5 A for 10 min. Membranes were cut in half to allow separate probing of the control protein β-tubulin (1:1000, Cell Signalling Technologies). The top half was initially blocked in 5% Bovine Serum Albumin (BSA, Sigma-Aldrich) and probed with p-Abl Y245 overnight prior to incubation with alkalinephosphatase (AP)-conjugated anti-rabbit immunoglobulin (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and detection with ECF substrate (GE Healthcare) by FluorImager analysis (Molecular Dynamics, Sunnyvale, CA, USA). Membranes were stripped with Western Stripping Buffer (Alpha Diagnostic, San Antonio, TX, USA), re-blocked in 5% BSA, probed with c-Abl overnight, then AP-conjugated anti-rabbit immunoglobulin (Cell Signalling Technologies) and detected with ECF as above. Detected proteins were quantified using ImageStudioLite 5.0 software and expression normalized to control.
